May 23, 2023 – Researchers at Mayo Clinic are developing a saliva test that could help identify the type of diabetes a person has. This test aims to provide a more personalized approach to diabetes treatment, moving away from a one-size-fits-all strategy. By understanding the specific type of diabetes, doctors can better determine which medications or treatments are likely to be most effective. This could include drugs like GLP-1 receptor agonists, which are known to work well for some but not all patients. The test is still in the pilot phase, with initial studies showing promise. However, experts caution that more independent studies are needed to validate these findings. If successful, this test could not only improve treatment outcomes but also reduce healthcare costs by targeting therapies to those most likely to benefit. Additionally, it could help reduce the stigma associated with diabetes by providing a clearer biological basis for the condition.